Yale Neurology Cited for Advances in Lancet
New Haven, Conn. — Papers published by clinicians and clinical researchers in Yale School of Medicine’s Department of Neurology have been cited as among the most important the past year in three crucial areas—stroke, movement disorders, and multiple sclerosis—in a survey of recent advances in Lancet Neurology.
In its survey of the most important advances in 2004, Lancet Neurology summarized the five most pivotal papers in each of 10 areas within neurology. The survey cited research carried out by Lawrence Brass, M.D., professor of neurology, that evaluated the efficacy of medications that prevent stroke; studies by Kenneth Marek, M.D., adjunct professor of neurology, on new neuro-imaging techniques that facilitate the accurate assessment of new medications for Parkinson’s disease; and research by Stephen Waxman, M.D., professor and chair of neurology, that identified molecules that trigger the degeneration of nerve fibers within the brain and spinal cord in multiple sclerosis.
Commenting on the Lancet survey, Waxman said, “even at a time of great financial challenge, the faculty of Yale’s Department of Neurology continues to make fundamental advances in our understanding of the diseases of the brain and spinal cord. I’m confident that we will ultimately conquer these disorders and cure them, and I’m incredibly proud that Yale’s faculty is at the forefront.”
PRESS CONTACT: Office of Public Affairs 203-432-1345